Download Funding News

Funding News
July 30, 2007
NEWS & NOTICES FOR THE WEEK ENDING July 27, 2007
NIH Requiring Electronic Financial Status Report System (FRS) Beginning October 1, 2007
[NOT-OD-07-078] (7/27) Requires all FSRs due on or after October 1 to be submitted via the
electronic system in eRA Commons. Does not affect other Federal agencies.
NIDCR Withdrawing from the NIH Small Research Grant Program [NOT-DE-07-004] (7/25)
Effective immediately.
NIDA Genetics Consortium Samples Available (7/23)
Institute funds numerous human genetics research projects aimed at identifying the genes that
confer susceptibility to drug abuse, drug addiction, and drug abuse-related behaviors. Access to
primary data and biomaterials generated by these studies may be gained through the NIDA Center
for Genetic Studies. See NOT-DA-07-019 for dates, etc.
DHHS finds Research Misconduct at UCLA [NOT-OD-07-079] (7/27)
Research Associate intentionally fabricated multiple interviews, urine samples, and urine sample
records of human subject study participants of NIDA-funded study.
FEDERAL SOLICITATIONS
NCI/NINR/OBSSR/NIGMS/NIDCD Biobehavioral Methods to Improve Outcomes Research –
R21 [PA-07-008] (10/13/06)
Receipt Dates
October 5, February 5, June 5 (standard R01)
Closes
September 2, 2008
Encourages methodological and technological innovation among biobehavioral studies that use
cancer as the disease paradigm and seek to improve clinical outcome (e.g., quality of life,
symptom management, disease progression).
Research using innovative methods to study the interface between behavioral factors (e.g., stress,
affect, coping), tumor biology (e.g., angiogenesis, T-cell regulation, inflammation, viral
oncogenesis) and other biological mechanisms (e.g., apoptosis, DNA repair), and cancer control
are appropriate.
NCI/NHLBI/OBSSR/NINR/NIDDK Health Promotion Among Racial and Ethnic Minority Males
– R01 [PA-07-422] (7/27)
Receipt Dates
October 5, February 5, June 5 (standard R01)
Closes
September 8, 2010
Seeks applications from applicants that propose to stimulate and expand research in the health of
minority men.
Goals
• Enhance our understanding of the numerous factors (e.g., sociodemographic, community,
societal, personal) influencing the health-promoting behaviors of racial and ethnic minority males
and their subpopulations across the life cycle
• Promote the development and testing of culturally and linguistically appropriate health-promoting
interventions designed to reduce health disparities among racially and ethnically diverse males
and their subpopulations age 21 and older
NCI/NHLBI/OBSSR/NINR/NIDDK Health Promotion Among Racial and Ethnic Minority Males
– R21 [PA-07-421] (7/27)
Receipt Dates
October 16, February 16, June 16 (standard R21)
Closes
September 8, 2010
See above.
NICHD/NIMH Diagnostic and Pharmacokinetic Research in Pediatric HIV/TB and Effects of
Co-infection on the Central Nervous System – R01 [RFA-HD-07-006 ] (7/23)
LOI
September 23, 2007
Receipt Date
October 23, 2007
Closes
October 28, 2007
Seeks applications from institutions/organizations that propose improved modalities for the
diagnosis of tuberculosis (TB) infection and disease, including MDR and XDR TB, in children with
HIV/TB co-infection.
Applications are also invited for the evaluation of the pharmacokinetics of first- and second-line
anti-tubercular medications, as well as pharmacokinetic drug interactions between these and
antiretroviral medications in children with HIV/TB co-infection. Finally, applications are solicited for
research to evaluate the effect of HIV/TB co-infection in children on the central nervous system.
Intentions of Initiative
• Stimulate research to improve the diagnosis and treatment of HIV-infected children with
tuberculosis (TB) co-infection
• Form a basis for future research and clinical care
Commitment
$1.9M for 3-6 applications
NIGMS/NIDA/NIMH/NINDS/NIAID Exceptional, Unconventional Research Enabling
Knowledge Acceleration (EUREKA) – R01 [RFA-GM-08-002] (7/23)
LOI
September 24, 2007
Receipt Date
October 24, 2007
Closes
October 25, 2007
Solicits applications from institutions/organizations proposing exceptionally innovative research on
novel hypotheses or difficult problems, solutions to which would have an extremely high impact in
biomedical or biobehavioral research that is germane to the mission of one or more of the
participating NIH Institutes.
Does not support pilot projects, i.e., projects of limited scope that are designed primarily to
generate data that will enable the PI to seek other funding opportunities.
Commitment
Award
Criteria
Over 4 years, $8.4M total: $5M to fund 13-17 applications (NIGMS) + $3.4M
(other Institutes combined)
This funding opportunity is non-renewable.
NIGMS Large-Scale Collaborative Project Awards – R24/U54 [PAR-07-412] (7/23)
Receipt Dates
Phase I: September 17, 2007-2009
2
Closes
Phase II: June 17, 2008-2010
June 18, 2010
Re-announces the program of large-scale collaborative project awards (glue grants), last issued as
PAR-04-128 in July, 2004. These awards are intended to solve critical, complex biological
problems within the mission of NIGMS by supporting a team of independently funded investigators
to synergize and integrate their research efforts.
Award
Requirements
Phase I: $50K for 1 year
Phase II: $25M over 5 years
Large-scale collaborative project awards must include a PI, participating
investigators, a steering committee, and an advisory committee.
NHLBI/NICHD/NIDDK/NINR Lymphatic Biology in Health and Disease — R01 [PAR-07-420]
(7/27)
LOI
August 27, 2007, August 16, 2008, and August 17, 2009
Receipt Dates
September 28, 2007, September 18, 2008, and September 18, 2009
Closes
September 19, 2009
Solicits applications from qualified researchers to investigate the biology of the lymphatic system
and potential new therapeutic implications.
Intentions of Initiative
• Stimulate research on the biology of the lymphatic system at all biologic levels: molecular,
cellular, tissue, organ, and whole body levels.
• Include research on innovations for identifying and intervening in lymphatic diseases across all
age groups and disease states.
ADDITIONAL SOLICITATIONS
• FIC International Research Ethics Education and Curriculum Development Award —
R25 [RFA-TW-08-002] (7/26)
• NICHD Mathematical Cognition and Specific Learning Disabilities — R01 [RFA-HD-07005] (7/23)
• NIGMS/NCMHD Bridges to the Baccalaureate Program — R25 [PAR-07-411] (7/23)
• NIGMS/NCMHD Bridges to the Doctorate Program — R25 [PAR-07-410] (7/23)
• NICHD/NIGMS/NINDS/NIDA/NIEHS Developmental Pharmacology — R01 [PAR-07-416]
(7/24)
• NIDA/NIAAA Genetic Epidemiology of Substance Use Disorders — R01, R03, R21 [PA07-413 ] [PA-07-414 ] [PA-07-415] (7/24)
• NIDCR Small Grant Program for New Investigators — R03 [PAR-07-418] (7/25)
• NIBIB/NCCAM/NCRR/NEI/NIA/NIAAA/… Neuroimaging Informatics Software
Enhancement for Improved Interoperability and Dissemination — R03 [PAR-07-417]
(7/25)
• NIMH Computational Tools for Research in Neuroscience, Behavioral Science, and
Mental Health: STTR — R41/R42 [PA-07-423] (7/27)
• NICHD Developmental Mechanisms of Human Structural Birth Defects — P01 [PA-07419] (7/27)
PRIVATE FOUNDATION SOLICITATIONS
José Carreras International Leukaemia Foundation Fellowship
Receipt Date
November 2, 2007 (by International mail)
3
For junior faculty, this fellowship funds research on the diagnosis, prevention, and cure of leukemia
and related hematologic malignancies.
Award
Requirements
Application
Up to 3 years @ $50K a year
• MD or PhD less than 10 years ago (first degree)
• Devote 80% effort to project
• Funding for Years 2 & 3 is conditional
Paper
Burroughs Wellcome Fund Clinical Scientist Awards in Translational Research
Receipt Date
August 15 (formerly Sept 1)
Solicits innovative proposals that bring novel ideas and new approaches to translational research.
Supports research that draws upon recently available discoveries in the basic biomedical sciences.
No large-scale clinical trials.
Brochure
Advisory Committee
2007 Recipients
Award
Commitment
Requirements
Application
$150K for up to 5 years
10 awards in 2008
• US citizen or permanent resident
• MD or MD-PhD in clinical subspecialty
• Assistant Prof or Associate Prof (preferably within 2 yrs of appt)
• Current medial license
• Established investigator
• Nominated by institution
• ProposalCentral (electronic)
Burroughs Wellcome Fund Career Awards for Medical Scientists
Receipt Date
October 1, 2007
Bridges advanced postdoctoral fellowship training and the early stages of faculty service. The NIH
Career Development Awards were modeled after this program. Postdoctoral portion lasts 1-2 years.
Research can be basic biomedical, disease-oriented, translational, molecular genetic, or
pharmacological epidemiology. Epidemiology researchers should contact BWF before applying.
Brochure
Advisory Committee
Grant Recipients
4
Award
Requirements
Application
$700K over 5 years (max of $95K postdoctoral years)
• Clinical fellow, resident, instructor (non-tenure track) or postdoc
• At least 2 yrs postdoctoral experience
• Medical degree from US/CA institution (or lisence to practice in US/CA)
• 75% effort to research-related activities
• Nominated by institution (5 nominations each)
• ProposalCentral (electronic)
The American Society of Nephrology M. James Scherbenske Grant
Receipt Date
November 15, 2007, March 15, 2008, and June 15, 2008
Bridge funding for investigators whose competitive renewal R01s were scored but not funded.
Application
Recipients
Award
Restrictions
$100K for 1 year (can include 10% indirect)
• Active member (dues paid no later than Feb 1 of application year)
• No more than $140K total extramural funding (direct costs)
• MD, PhD or equiv degree
• Full-time faculty
• ≥ 75% time available research (all projects)
Lymphoma Research Foundation Postdoctoral Fellowships
Receipt Date
September 4, 2007
Two-year fellowships designed to attract the nation's best scientific talent to careers in lymphoma
and allow them to pursue promising leads under the guidance of a Sponsor.
Guidelines
Policy, Terms, and Conditions
Award
Requirements
Application
Year I: $50K, Year II: $55K
• Must have completed 2 years of postdoctoral fellowship and not more than 2
years as junior faculty instructor or assistant professor
• Must hold MD, PhD, or equiv.,
• Must secure unique sponsor who will supervise proposed research project.
• Minimum of 80% effort in research without major patient care, teaching, or
administrative responsibilities unless they relate directly to a pre-clinical or
clinical lymphoma research project
• Can’t hold another competitive fellowship title during LRF grant period.
proposalCENTRAL (electronic)
Lymphoma Research Foundation Career Development Awards (CDA)
Receipt Date
September 4, 2007
5
This three-year program funds training of clinicians who will participate in developing new
therapeutics and diagnostic tools for lymphoma. Clinicians will be trained to design and administer
clinical studies and to take on primary responsibility for trial design, protocol development, IRB
submission, and publication.
A Career Development Plan and the commitment of a mentor are required as part of the grant
application.
Guidelines
Policy, Terms and Conditions
Award
Commitment
Requirements
Criteria
$75K a year for 3 years
3 awards annually
Applicants:
1. Must be licensed physicians at a clinical research institution in
US/Canada
2. Should be advanced fellow or junior faculty up to the level of assistant
professor - must also possess at least 2 years of training in hematology
and/or oncology, plus clinical experience managing patients with
lymphoma
3. Must have unique Primary Mentor who will oversee the applicant’s
research training.
4. Clinical Investigator must spend at least 50% of time in research.
5. May not hold another competitively applied for fellowship or career
development award during the period of the LRF Grant
proposalCENTRAL (electronic).
APPROACHING DEADLINES
The following programs have been summarized in previous issues of Funding News, which are available on
the Cancer Center website under Research/Grants/Summary Information. (Red indicates that an LOI or preapplication was required prior to the application date.)
Due Date
Program
More Info
Issue #
August 8
– LOI
Alliance for Cancer Gene Therapy (ACGT) Young
Investigators Award
23
August 8
– LOI
ACGT Investigators Award in the Clinical Translation of Gene
Therapy for Cancer
23
August 8
PAR-07-384
20
August
10
NCCAM Ruth L. Kirschstein NRSA for Individual Predoctoral
Fellowship Training in Complementary and Alternative Medicine
– F31
CDC/OPHR Grants for Public Health Research Dissertations –
R36 (LOI due 30 days prior)
PAR-07-231
22
August
14
FIC/NCI/NIAAA/NIAID/NIDCR/NIDA/NINH/NINR/ORWH AIDS
International Training and Research Program – D43
PAR-07-239
12
August
14
NIDCR Oral Mucosal Vaccination against HIV Infection – R01,
R21
RFA-DE-08-003
RFA-DE-08-004
12
August
14 – LOI
NIH Roadmap National Institutes of Health Rapid Access to
Interventional Development (NIH-RAID Pilot) – X01
PAR-07-358
14
6
August
15
Burroughs Wellcome Fund (BWF) Clinical Scientists Awards in
Basic Research
12
August
15
American Society of Clinical Oncology (ASCO) ACRA in
Hematological Malignancies
21
August
17
August
17 – LOI
NCRR High End Instrumentation Grant Program – S10
PAR-07-383
20
NCCAM/NCRR/NEI/NIAAA/NIA/NIBIB/NICHD… NIH Blueprint
for Neuroscience Research Tools and Techniques for
Elucidating and Manipulating Neural Circuit Development –
R21
Lustgarten Foundation for Pancreatic Cancer Research
RFA-MH-08-060
23
NIDA/NIEHS Mechanism for Time-Sensitive Research
Opportunities – R21 (LOI due 1 month prior)
PAR-07-345
11
August
20 – LOI
NIDA/NIEHS Mechanism for Time-Sensitive Research
Opportunities – R21
PAR-07-345
11
August
20 – LOI
NHGRI A Data Analysis Center for the Encyclopedia of DNA
Elements (ENCODE) Project – U01
RFA-HG-07-010
23
August
20 – LOI
NICHD Population Research Infrastructure Program – R01
RFA-HD-07-009
22
August
21
Specialized Programs of Research Excellence (SPORES) In
Human Cancer for the Year 2007
PAR-06-505
20
August
21 – LOI
Specialized Programs of Research Excellence (SPOREs) in
Human Cancer, 2007 – P50
PAR-06-505
1
August
21– LOI
NIH FIC/NCI/NIA/NIBIB/NIEHS/NINDS/ODS Global Research
Initiative Program, Basic/Biomedical Sciences – R01
PAR-07-239
10
August
24
Avon Foundation – Breast Cancer Prevention Research
Initiative
August
27 – LOI
NIH NCI Application of Emerging Technologies for Cancer
Research – R21, R33, SBIR(R43,R44), STTR(R41,42)
RFA-CA-07-035
RFA-CA-07-036
RFA-CA-07-041
RFA-CA-07-042
3
August
27 – LOI
NIH NCI Innovations In Cancer Sample Preparation –
SBIR(R43,R44), STTR(R41,42)
RFA-CA-07-043
RFA-CA-07-044
3
August
27 – LOI
NIH NCI Innovative Technologies for Molecular Analysis of
Cancer (IMAT) – R21, R33, SBIR(R43,R44), STTR(R41,42)
RFA-CA-07-033
RFA-CA-07-034
RFA-CA-07-039
RFA-CA-07-040
3, 16
August
29
NIH NIGMS Molecular Probes for Microscopy of Cells – R01
PAR-07-234
9
August
31
Robert Wood Johnson Foundation Physician Faculty Scholars
Program
20
Sept. 4
American Lung Association – Research Grants, Clinical
Research Grants, Career Investigators; Training Awards, and
17
August
20
August
20
22
17
7
Alliance Awards
Sept. 4
NIHM National NeuroADIS Tissue Consortium (NNTC) Data
Coordinating Center (DCC) – U01
RFA-MH-08020
17
Sept 5.
American Gastrological Association: Funderburg Research
Research Scholar Award, Bridging Grant
19
Sept 6 –
LOI
Concern Foundation Conquer Cancer Now Award
18
Sept. 7
NCI/NBIB/NEI/NHLBI/NHGRI/NIA/NIAMS/NICHD/NIDA/NIDCD/
NIDCR/NIEHS/NINDS Bioengineering Research Partnerships –
R01
Sept. 7
Standard AIDS-related applications due, including:
• NIDA AIDS-Science Track Award for Research Transition (ASTART) – R03
PAR-07-352
12
PAR-07-347
12
RFA-HS-08-001
20
Sept. 10
– LOI
AHRQ/OEREP National Research Service Award Institutional
Research Training Grant – T32
Sept. 14
Cancer Research and Prevention Foundation (CRPF) Grants
and Fellowship Program
Sept. 14
NIH Roadmap National Institutes of Health Rapid Access to
Interventional Development (NIH-RAID Pilot) – X01
PAR-07-358
14
Sept. 14
NCI / NCAAM Omics and Variable Responses to CAM:
Secondary Analysis of CAN clinical Trials – R01, R21
PAR-07-378
19
Sept. 15
Cancer Research and Prevention Foundation CRPF Grants and
Fellowships Program
4
Sept. 17
– Pre-app
Leukemia and Lymphoma Society Career Development Program
19
Sept. 17
NCCAM/NCRR/NEI/NIAAA/NIA/NIBIB/NICHD… NIH Blueprint
for Neuroscience Research Tools and Techniques for
Elucidating and Manipulating Neural Circuit Development –
R21 (LOI due 1 month prior)
RFA-MH-08-060
23
Sept. 17
NCRR High-End Instrumentation Grant Program – S10
PAR-07-383
20
Sept. 18
– LOI
NCI/NIAID/NHLBI/NIAAA/NICHD/NIDA/NIMH U.S.-India Bilateral
Collaborative Research Partnerships (CRP) on the Prevention of
HIV/AIDS – R21
RFA-AI-07-031
23
Sept. 19
NICHD Population Research Infrastructure Program – R01
RFA-HD-07-009
22
Sept. 19
NIH/OBSSR/NCCAM/NEI/NHLBI/NIAMS/NIAID/NICHD/NIDCR/N
IDDK/NIEHS/NIGMS/NIMH/NINDS/NINR/NIA/NIAAA/NICHD/NID
A/NILM/OPHR/(CDC) Behavioral and Social Science Research
on Understanding and Reducing Health Disparities – R01, R21
PAR-07-379
PAR-07-380
19
Sept. 19
– LOI
NIH/OBSSR/NCCAM/NEI/NHLBI/NIAMS/NIAID/NICHD/NIDCR/N
IDDK/NIEHS/NIGMS/NIMH/NINDS/NINR/NIA/NIAAA/NICHD/NID
A/NILM/OPHR/(CDC) Behavioral and Social Science Research
on Understanding and Reducing Health Disparities – R01, R21
PAR-07-379
PAR-07-380
19
12
8
Sept. 19
– LOI
NIDA/NIEHS Mechanism for Time-Sensitive Research
Opportunities – R21
PAR-07-345
11
Sept. 20
NHGRI A Data Analysis Center for the Encyclopedia of DNA
Elements (ENCODE) Project – U01
RFA-HG-07-010
23
Sept. 20
NIDA/NIEHS Mechanism for Time-Sensitive Research
Opportunities – R21 (LOI due 1 month prior)
PAR-07-345
11
Sept. 20
NIH Framework Programs for Global Health - R25
RFA-TW-08-001
15
Sept. 21
NIH FIC/NCI/NIA/NIBIB/NIEHS/NINDS/ODS Global Research
Initiative Program, Basic/Biomedical Sciences – R01
PAR-07-239
10
Sept. 21
FIC/NCCAM/NIA/NIAAA/NIBIB/NIDCD/NIDCR/NIDA/NIEHS/NIN
DS International Research Collaboration – Basic Biomedical
(FIRCA-BB) – R03
PAR-07-335
10
Sept. 24
– LOI
NIGMS Research on Interventions that Promote Research
Careers R01
RFA-GM-08-005
19
Sept. 25
NIH NCI Cancer Education and Career Development Program –
R25
PAR-06-511
3
Sept. 26
– LOI
NIDA Criminal Justice Drug Abuse Treatment Studies 2 – U01
RFA-DA-08-002
22
Sept. 27
NIH NCI Application of Emerging Technologies for Cancer
Research – R21, R33
RFA-CA-07-035
RFA-CA-07-036
3
Sept. 27
NIH NCI Innovative Technologies for Molecular Analysis of
Cancer (IMAT) – R21, R33, SBIR(R43,R44), STTR(R41,42)
RFA-CA-07-033
RFA-CA-07-034
3, 16
Sept. 28
NIH NCI Innovative Technologies for Molecular Analysis of
Cancer (IMAT) –SBIR(R43,R44), STTR(R41,42)
RFA-CA-07-039
RFA-CA-07-040
3, 16
Sept. 28
NIH NCI Application of Emerging Technologies for Cancer
Research –SBIR(R43,R44), STTR(R41,42)
RFA-CA-07-041
RFA-CA-07-042
3
Sept. 28
NIH NCI Innovations In Cancer Sample Preparation –
SBIR(R43,R44), STTR(R41,42)
RFA-CA-07-043
RFA-CA-07-044
3
Sept. 28
– LOI
NHLBI Summer Institute Program to Increase Diversity in HealthRelated Research (SIPID) – R25
RFA-HL-07-012
17
Sept. 28
Beckman Foundation Beckman Young Investigator Program
21
Sept. 28
Louisiana Breast Cancer Task Force Health, Services,
Education, and Outreach Grants
22
Oct. 1
Charlotte Geyer Foundation
13
Oct. 1
Wendy Will Case Cancer Fund
14
Oct. 1
Burroughs Wellcome Fund – Biomedical Scientists
18
Oct. 1
Parker B. Francis Fellowship in Pulmonary Research
19
Oct. 1
NCI Clinical Correlative Studies: Exploratory Studies in Cancer
PA-05-165
15
9
Detection, Diagnosis and Prognosis – R21
Oct. 1
Leukemia and Lymphoma Society Career Development Program
19
Oct. 3
Alliance for Cancer Gene Therapy (ACGT) Young
Investigators Award
23
Oct. 3
ACGT Investigators Award in the Clinical Translation of Gene
Therapy for Cancer
23
Oct. 5
Standard R01 applications due
Oct. 5
NHLBI Investigator Initiated Multi-Site Clinical Trials – R01
Oct. 8
Cancer Treatment Research Foundation
Oct. 12
Standard Career Development (K) applications due, including:
• NHLBI/NIDDK/NIAAA/NIEHS Career Enhancement Award for
Stem Cell Research – K18
• NIH Pathway to Independence (PI) Award (K99/R00)
PAR-07-373
19
16
PAR-07-358
PA-07-297
14
18
Oct. 15
American Cancer Society (ACS)
• Cancer Control Career Development Awards for Primary Care
Physicians
• Postdoctoral Fellowships
• Doctoral Training Grants in Oncology Social Work
• Master's Training Grants in Clinical Oncology Social Work
• Physician Training Awards in Preventive Medicine
• Doctoral Degree Scholarships in Cancer Nursing
3S
Oct. 15
ACS Mentored Research Scholar Grant in Applied and Clinical
Research
2S
Oct. 15 –
LOI
NCI-Avon “Progress for Patients” (PFP) Awards for Early Phase
Clinical Interventions and Biomarkers in Breast Cancer (Limited
Competitive Supplements [Revisions] for P30 Cancer Center
Support Grants)
PAR-07-244
10
Oct. 15 –
LOI
Oct. 15
Oct. 16
NIH Centers for Research to Reduce Disparities in Oral Health –
U54 (Cooperative Agreement)
Parker B. Francis Fellowships in Pulmonary Research
Standard R03, R21, R33, R34, and R36 applications due
RFA-DE-08-008
15
Oct. 16
NCI/ORWH/NEI/NHLBI/NHGRI/NIA/NIAA/NIAAA/NIAID/NIAMS/
NICHD/NIDCD/NIDCR/NIDA/NIEHS/NIGMS/NIMH/NINDS/NINR/
NLM/FIC/NICCAM/OBSSR/ODS Advancing Novel Science in
Women’s Health Research (ANSWHR) - R21 (new apps)
PAS-07-382
20
Oct. 16
NCI/ORWH/NEI/NHGRI/NIAAA/NIAMS/NICHD/NIDCR/NIDA/NIE
HS/NIMH/NINDS/NLM/FIC/NICCAM/OBSSR/ODS Advancing
Novel Science in Women’s Health Research (ANSWHR) – R03
(new apps)
PAS-07-382
20
Oct. 16
American Liver Foundation Postdoctoral Research
Fellowship Awards
21
Oct. 19 –
LOI
Thrasher Research Fund (clinical/translational pediatric
research)
15
Oct. 18
NCI/NIAID/NHLBI/NIAAA/NICHD/NIDA/NIMH U.S.-India Bilateral
Collaborative Research Partnerships (CRP) on the Prevention of
23
RFA-AI-07-031
23
10
HIV/AIDS – R21 (LOI due 1 month prior)
Oct. 19
AHRQ/OEREP National Research Service Award Institutional
Research Training Grant – T32
RFA-HS-08-001
20
Oct. 19
NIDA/NIEHS Mechanism for Time-Sensitive Research
Opportunities – R21 (LOI due 1 month prior)
PAR-07-345
11
Oct. 20 –
LOI
NIDA/NIEHS Mechanism for Time-Sensitive Research
Opportunities – R21
PAR-07-345
11
Oct. 22 –
LOI
NIA/NICHD Studies to Identify Possible Juvenile Protective
Factors and their Effects on Aging – R01
RFA-AG-08-003
23
Oct. 22
NIGMS Research on Interventions that Promote Research
Careers R01
RFA-GM-08-005
19
Oct. 23
NIGMS/NIEHS Collaborative Studies on Systems Biology of
Complex Phenotypes – R01
PAR-07-358
14
Oct. 26
Oct. 29
NIDA Criminal Justice Drug Abuse Treatment Studies 2 – U01
NHLBI Summer Institute Program to Increase Diversity in HealthRelated Research (SIPID) – R25
RFA-DA-08-002
RFA-HL-07-012
22
17
Oct. 29 –
LOI
NCI/NINR NINR Nursing Science Research on Interventions in
Chronic Illness—P01
RFA-NR-08-001
20
Nov. 14 –
LOI
NIAAA Exploratory/Developmental Alcohol Research CentersP20
RFA-AA-08-003
22
Nov. 14 –
LOI
NIAAA Resource Core Alcohol Research Centers – P30
RFA-AA-08-004
22
Nov. 14 –
LOI
NIAAA Specialized Alcohol Research Centers – P50
RFA-AA-08-005
22
Nov. 14 –
LOI
NIAAA Comprehensive Alcohol Research Centers – P60
RFA-AA-08-006
22
Nov. 14
NCI/NCCAM Mechanisms of Immune Modulation – R01, R21
RFA-AT-07-004
RFA-AT-07-005
23
Nov. 15
NCI-Avon “Progress for Patients” (PFP) Awards for Early Phase
Clinical Interventions and Biomarkers in Breast Cancer (Limited
Competitive Supplements [Revisions] for P30 Cancer Center
Support Grants)
PAR-07-244
10
Nov. 15
NIH Centers for Research to Reduce Disparities in Oral Health –
U54 (Cooperative Agreement)
NCI/ORWH/NEI/NHLBI/NHGRI/NIA/NIAA/NIAAA/NIAID/NIAMS/
NICHD/NIDCD/NIDCR/NIDA/NIEHS/NIGMS/NIMH/NINDS/NINR/
NLM/FIC/NICCAM/OBSSR/ODS Advancing Novel Science in
Women’s Health Research (ANSWHR) - R21 (resubmissions)
RFA-DE-08-008
15
PAS-07-381
20
Nov. 16
NCI/ORWH/NEI/NHGRI/NIAAA/NIAMS/NICHD/NIDCR/NIDA/NIE
HS/NIMH/NINDS/NLM/FIC/NICCAM/OBSSR/ODS Advancing
Novel Science in Women’s Health Research (ANSWHR) – R03
(resubmissions)
PAS-07-382
20
Nov. 19
NIA/NICHD Studies to Identify Possible Juvenile Protective
Factors and their Effects on Aging – R01
RFA-AG-08-003
23
Nov. 16
11
Nov. 20
NIDA/NIEHS Mechanism for Time-Sensitive Research
Opportunities – R21 (LOI due 1 month prior)
PAR-07-345
11
Nov. 20 –
LOI
NIDA/NIEHS Mechanism for Time-Sensitive Research
Opportunities – R21
PAR-07-345
11
Nov. 20
Thrasher Research Fund (clinical/translational pediatric
research) (LOI due June 16)
Nov. 26
NCI/NINR Nursing Science Research on Interventions in Chronic
Illness—P01
Dec. 1
Concern Foundation Conquer Cancer Now Award
18
Dec. 1 –
LOI
Gerber Foundation Grants
15
Dec. 1
US Immunodeficiency Network (USIDNET) Grants Program
23
Dec. 5
Kimmel Foundation Translational Science Award
2S
Dec. 5
Kimmel Foundation Kimmel Scholars Award for Cancer
Research
20
Dec.8
NIH NCCAM Ruth L. Kirshstein NSRA for Postdoctoral Training
in Complementary and Alternative Medicine – F32
Dec. 14
American Institute for Cancer Research (AICR) Investigator
Initiated Grant (IIG) and Post-Doctoral Grant Award (PDA)
Dec. 14
NIAAA Exploratory/Developmental Alcohol Research Centers –
P20 (LOI due 1 month prior)
RFA-AA-08-003
22
Dec. 14
NIAAA Resource Core Alcohol Research Centers – P30 (LOI
due 1 month prior)
RFA-AA-08-004
22
Dec. 14
NIAAA Specialized Alcohol Research Centers – P50 (LOI due 1
month prior)
RFA-AA-08-005
22
Dec. 14
NIAAA Comprehensive Alcohol Research Centers – P60 (LOI
due 1 month prior)
RFA-AA-08-006
22
Dec. 15
NIH Roadmap National Institutes of Health Rapid Access to
Interventional Development (NIH-RAID Pilot) – X01
PAR-07-358
14
Dec. 20
NIDA/NIEHS Mechanism for Time-Sensitive Research
Opportunities – R21 (LOI due 1 month prior)
PAR-07-345
11
Dec. 21 –
LOI
NIDA/NIEHS Mechanism for Time-Sensitive Research
Opportunities – R21
PAR-07-345
11
15
RFA-NR-08-001
PAR-07-319
20
6
14
12
GENERAL INFORMATION○
Unless otherwise specified, for each program description summarized in Funding News,
the following guidelines apply:
•
•
Dollar amounts represent direct costs.
•
•
•
NIH R03 awards are up to of $200K over two years and are nonrenewable.
•
•
Applicants/Institutions can submit more than one application.
•
•
No institutional restrictions other than the general NIH standards apply.
•
For programs with multiple participating Institutes, the sponsoring Institute is
underlined.
•
NIH R01 awards are for unspecified amounts that are dependant on available
funding and the nature of applications received; they are renewable.
NIH R21 awards are up to $275K over two years and are nonrenewable.
NIH AIDS-related proposals are associated with the standard receipt dates May 7,
September 7 and January 7.
All applicants with the skills, knowledge and resources necessary to perform
proposed research are eligible.
Not every NIH Institute and Centers supports all types of funding mechanisms. For
example, when co-sponsoring an initiative, NEIHS may offer both R01 and R03
award mechanisms, whereas NIE will offer only the former.
In the table of Approaching Deadlines, dates in red indicate that a pre-application or
LOI was due.
○
Applicable unless otherwise specified
No. 24, July 30, 2007
Hope Oddo,
Jonna Ellis,
&
Heidi Davis
Office of Grants and Development
[email protected]
13